We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$133M
AUM Growth
+$4.83M
Cap. Flow
+$239K
Cap. Flow %
0.18%
Top 10 Hldgs %
21.28%
Holding
576
New
26
Increased
109
Reduced
176
Closed
24

Top Sells

Rank Stock Value
1
LEA icon
Lear
LEA
+$2.96M
2
CAVM
Cavium, Inc.
CAVM
+$2.83M
3
TSS
Total System Services, Inc.
TSS
+$2.77M
4
DHI icon
D.R. Horton
DHI
+$2.74M
5
CPAY icon
Corpay
CPAY
+$2.5M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Industrials 16.54%
3 Consumer Discretionary 16.03%
4 Healthcare 11.88%
5 Consumer Staples 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBL icon
101
Jabil
JBL
$35.3B
$68K 0.05%
3,520
+605
+21% +$12.2K
FR icon
102
First Industrial Realty Trust
FR
$8.36B
$67K 0.05%
+2,962
New +$62.4K
WCG
103
DELISTED
Wellcare Health Plans, Inc.
WCG
$57K 0.04%
618
-96
-13% -$7.96K
MOH icon
104
Molina Healthcare
MOH
$10.4B
$54K 0.04%
839
-59
-7% -$3.5K
DINO icon
105
HF Sinclair
DINO
$15.2B
$52K 0.04%
1,470
+53
+4% +$1.83K
X
106
DELISTED
US Steel
X
$52K 0.04%
3,262
-3,599
-52% -$35.9K
SNX icon
107
TD Synnex
SNX
$20.3B
$51K 0.04%
1,102
+806
+272% +$36K
JCP
108
DELISTED
J.C. Penney Company, Inc.
JCP
$51K 0.04%
4,587
-2,528
-36% -$22.1K
ACH
109
Accendra Health
ACH
$107M
$46K 0.03%
1,140
-134
-11% -$4.99K
DNY
110
DELISTED
DONNELLEY R R & SONS CO
DNY
$46K 0.03%
2,802
-398
-12% -$6.53K
CST
111
DELISTED
CST Brands, Inc.
CST
$45K 0.03%
1,184
+92
+8% +$3.38K
MUSA icon
112
Murphy USA
MUSA
$10.2B
$42K 0.03%
678
-139
-17% -$8.55K
RGA icon
113
Reinsurance Group of America
RGA
$15.8B
$42K 0.03%
440
-52
-11% -$4.58K
GLD icon
114
SPDR Gold Trust
GLD
$143B
$41K 0.03%
350
CSC
115
DELISTED
Computer Sciences
CSC
$40K 0.03%
1,150
-461
-29% -$13.9K
WNR
116
DELISTED
Western Refining Inc
WNR
$40K 0.03%
1,382
+195
+16% +$5.88K
RS icon
117
Reliance Steel & Aluminium
RS
$21.9B
$39K 0.03%
567
-144
-20% -$8.71K
JAH
118
DELISTED
JARDEN CORPORATION
JAH
$37K 0.03%
635
UNFI icon
119
United Natural Foods
UNFI
$2.8B
$34K 0.03%
840
+28
+3% +$1.03K
GNW icon
120
Genworth Financial
GNW
$3.75B
$33K 0.02%
12,222
+2,683
+28% +$6.79K
STLD icon
121
Steel Dynamics
STLD
$38.5B
$33K 0.02%
1,450
-549
-27% -$10.3K
AVP
122
DELISTED
Avon Products, Inc.
AVP
$33K 0.02%
6,799
-1,272
-16% -$4.54K
HII icon
123
Huntington Ingalls Industries
HII
$13B
$31K 0.02%
227
ORI icon
124
Old Republic International
ORI
$10.3B
$31K 0.02%
1,678
+25
+2% +$451
TEX icon
125
Terex
TEX
$7.58B
$31K 0.02%
1,228
-246
-17% -$5.15K

Similar funds

Weaver C. Barksdale & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Weaver C. Barksdale & Associates held 576 positions worth $133M, up 3.8% from $128M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates's Q1 2016 filing shows 26 new, 109 increased, 176 reduced and 24 closed positions. Its largest new stake was Cantel Medical Corporation: 39,396 shares worth $2.81M. The largest sale was Lear, an estimated $2.96M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Weaver C. Barksdale & Associates's largest Q1 2016 buy was Cantel Medical Corporation: 39,396 shares worth $2.81M.
  • Weaver C. Barksdale & Associates added most to Align Technology in Q1 2016, an estimated $2.45M increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2016 reduction was Manhattan Associates, cutting an estimated $2.26M.
  • Weaver C. Barksdale & Associates fully exited Lear in Q1 2016, selling an estimated $2.96M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $133M portfolio in Q1 2016.
  • Weaver C. Barksdale & Associates opened 26 new positions and closed 24 in Q1 2016.
  • Weaver C. Barksdale & Associates's portfolio value rose 3.8% quarter-over-quarter to $133M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2016, filed 5 Apr 2016.